Post-earnings recap
Reported
Wed, Aug 5, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's strong EPS performance indicates effective cost management and operational efficiency. The stock's slight increase of 0.09% reflects investor confidence, despite the lack of revenue data and future guidance. This quarter's results may suggest resilience in their business model amid ongoing market challenges.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.33 | N/A | +37.40% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the earnings beat, highlighting their commitment to innovation. However, they did not provide specific guidance for the upcoming quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on delivering innovative solutions to our customers.